Skip to content

Clinical trials

Inflammation trials in Norway with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Status: Unknown status Country / region: Norway Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20161
20182
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Akershus2
Epax Norway AS1
Helse Stavanger HF1
Nordlandssykehuset HF1
Oslo University Hospital1
Ullevaal University Hospital1
University Hospital of North Norway1
University Hospital, Aker1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation9
Cognitive Dysfunction2
Dementia2
Diabetes Mellitus, Type 22
Brain Diseases1
COVID-191
Central Nervous System Diseases1
Cognition Disorders1
Coronary Artery Disease1
Glucose Intolerance1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.